Rotavirus vaccines in routine use (Q26853690)

language of work or name

1 reference

1 November 2014

1 reference

Clinical Infectious Diseases

published in

1 reference

volume

59

1 reference

issue

9

1 reference

page(s)

1291-301

1 reference

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Global mortality associated with rotavirus disease among children in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Global Illness and Deaths Caused by Rotavirus Disease in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Intussusception, rotavirus, and oral vaccines: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Failure of live, attenuated oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus vaccines: current prospects and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Meeting of the Strategic Advisory Group of Experts on immunization, October 2009--Conclusions and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Change in rotavirus epidemiology in northeast Florida after the introduction of rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El Salvador

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction into the South African Public Immunization Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Duration of protection of pentavalent rotavirus vaccination in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of rotavirus vaccination in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of monovalent and pentavalent rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Risk of intussusception after monovalent rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Intussusception risk after rotavirus vaccination in U.S. infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus vaccine introduction in the Americas: progress and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Rotavirus vaccines—An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564

Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU564